Search filters

List of works by John McMurray

"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? ⬇️

scientific article published on January 1, 2002

'Hearts and minds': association, causation and implication of cognitive impairment in heart failure

scientific article

17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women

scientific article published in January 2004

2010 Focused Update of ESC Guidelines on device therapy in heart failure

article published November 2010 in European Journal of Heart Failure

2010 Focused Update of ESC Guidelines on device therapy in heart failure

article published 1 November 2010 in EP Europace

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

scientific article

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

article

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

scientific article (publication date: 15 October 2013)

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

scientific article

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

article by Paulus Kirchhof et al published 27 August 2016 in EP Europace

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

scientific article

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

scientific article published in February 2018

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

scientific article published in March 2018

A comparison of laryngeal mask airway with tracheal tube for intra-ocular ophthalmic surgery

scientific article published on August 1, 1992

A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

scientific article (publication date: May 2007)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.

scientific article published on 19 April 2013

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

scientific article

A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction

scientific article published on 10 October 2014

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

scientific article

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction

scientific article published on 28 March 2020

A qualitative study of the contribution of pharmacists to heart failure management in Scotland

scientific article

A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure

scientific article published on 27 December 2007

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure

scientific article published on 6 April 2007

A review of quality-of-life evaluations in patients with congestive heart failure.

scientific article

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

scientific article

A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design

scientific article published on January 2011

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

scientific article published on 30 October 2009

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

scientific article published on 21 March 2019

A1 H spin echo and 51V NMR study of the interaction of vanadate with intact erythrocytes

ACE Inhibitors after myocardial Infarctlon

scientific article published in The Lancet

ACE inhibitors and health-care economics ⬇️

scientific article published on April 1, 1995

ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.

scientific article published in May 2001

Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial

scientific article

Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study

scientific article published on March 2016

Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF.

scientific article published on 4 November 2014

Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure

scientific article published on 01 October 1993

Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study

scientific article published on 5 January 2015

Acute heart failure: have we got it all wrong?

article

Acute ischemic events in HF—should we include sudden death?

scientific article published on 22 February 2011

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

scientific article

Adherence to medication according to sex and age in the CHARM programme

article

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

scientific article published on 3 May 2007

Age- and Sex-Specific Trends in Fatal Incidence and Hospitalized Incidence of Stroke in Scotland, 1986 to 2005

article

Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction

scientific article published on 01 August 2019

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

scientific article published in The Lancet

Albuminuria in chronic heart failure: prevalence and prognostic importance

scientific article published in August 2009

Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.

scientific article published on 10 January 2017

Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction.

scientific article

Aldosterone status associated with insulin resistance in patients with heart failure--data from the ALOFT study.

scientific article

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

scientific article published on 14 January 2009

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial

scientific article published on 25 September 2017

Aliskiren in Type 2 Diabetes and Cardiorenal End Points ⬇️

scientific article published on March 14, 2013

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

scientific article published on April 2012

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

scientific article published on 4 April 2016

Aliskiren, Enalapril, or Both in Heart Failure

scientific article published on 01 August 2016

Alteration of the erythrocyte glutathione redox balance by N -acetylcysteine, captopril and exogenous glutathione

article

Altered diaphragm position and function in patients with chronic heart failure

article

Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality

scientific article

Amlodipine for all undergoing PCI? The evidence is unconvincing

article

An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?

scientific article published in September 2002

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

scientific article published on January 2010

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

scientific article published in November 2004

Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction☆

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved ⬇️

scientific article published on 18 December 2013

Analysis of reproducibility of reference lumen quantitation with intravascular ultrasound in stented coronary arteries.

scientific article published in January 1997

Anemia and heart failure

scientific article

Anemia and its relationship to clinical outcome in heart failure.

scientific article published on 21 June 2004

Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: impact on general and mental health, quality of life and five-year mortality.

scientific article published on 15 June 2012

Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial

scientific article published on 26 June 2017

Angiotensin Receptor-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: Lessons from PARAGON-HF

scientific article published on 02 August 2020

Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?

scientific article published in March 2004

Angiotensin receptor blockers in heart failure ⬇️

scientific article published on September 1, 2003

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

scientific article

Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction

scientific article published on 02 June 2018

Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction

scientific article published on 17 August 2020

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

scientific article published on 01 September 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply

scientific article published on 01 March 2020

Angiotensin-neprilysin inhibition versus enalapril in heart failure

scientific article (publication date: 11 September 2014)

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

scientific article published in February 2005

Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis

scientific article published on 08 April 2019

Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA

scientific article published on 23 October 2018

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy

scientific article published on 4 February 2013

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

scientific article published in March 2010

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 20 October 2013

Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry

scientific article published in 2022

Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.

scientific article published on 30 January 2007

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

scientific article

Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure

scientific article (publication date: August 2005)

Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi

scientific article published on 30 March 2010

Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review

scientific article (publication date: September 2015)

Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow

scientific article

Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) tri

scientific article published on 20 January 2012

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.

scientific article

Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infar

scientific article published on 4 January 2018

Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction

scientific article published on 30 June 2014

Association is not causation: treatment effects cannot be estimated from observational data in heart failure

article

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

article

Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.

scientific article

Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial

scientific article published in March 2006

Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure

scientific article published on 02 September 2019

Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study

scientific article published in April 2011

Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA.

scientific article

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

scientific article published on 14 April 2019

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

scientific article published on 27 April 2006

Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

scientific article published on 20 April 2010

Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

scientific article published on 04 February 2013

Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man

scientific article published on 01 January 1988

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians

scientific article published on 27 May 2008

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial

scientific article published on 04 March 2019

B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review

scientific article

Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization

scientific article published on 26 September 2017

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

scientific article

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

article

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

scientific article published on 01 July 2018

Baseline characteristics and enrichment results of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial

scientific article published on 31 March 2018

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme

scientific article published on 31 March 2010

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).

scientific article

Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

article

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

scientific article published in November 2013

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

scientific article published on 17 January 2013

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials

scientific article published on 23 February 2010

Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial

scientific article published on 4 November 2009

Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme

scientific article published on 5 November 2008

Beta-blockers and heart failure in older people: reply

Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis

scientific article published on 04 February 2013

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

scientific article published on 10 October 2017

Beta-blockers, ventricular arrhythmias, and sudden death in heart failure: not as simple as it seems

scientific article published on 01 August 2000

Biochemical detection of left-ventricular systolic dysfunction ⬇️

scientific article published on January 3, 1998

Biomarkers in heart failure: a clinical review.

scientific article published on 03 December 2008

Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.

scientific article

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

scientific article published on 12 October 2020

Body Mass Index and Prognosis in Patients With Chronic Heart Failure

article

Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure

scientific article published on 20 February 2020

Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice ⬇️

scientific article published on December 1, 1997

C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

scientific article published on 16 September 2016

CAPTOPRIL, ENALAPRIL, AND BLOOD GLUCOSE

scientific article published in The Lancet

CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials

scientific article

CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin–angiotensin–aldosterone system the cornerstone of therapy for systolic heart failure ⬇️

scientific article published on 03 August 2011

Calcium Handling in the Failing Heart and SUMO — Weighing the Evidence

article

Calcium-antagonist controversy: the long and short of it?

scientific article published in The Lancet

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

scientific article published on 13 November 2020

Cardiac and Extracardiac Abnormalities Detected by Cardiac Magnetic Resonance in a Post-Myocardial Infarction Cohort

Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

scientific article

Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction

scientific article published on 09 January 2020

Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis.

scientific article published on 11 August 2015

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

scientific article published on 14 August 2019

Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.

scientific article published in April 2005

Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans ⬇️

scientific article published on 01 November 1997

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

scientific article

Chagas disease: still a neglected emergency?

scientific article published on 01 April 2020

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference.

scientific article

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

scientific article

Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.

scientific article published on 29 April 2015

Changes in notions about heart failure.

scientific article

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

scientific article

Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.

scientific article published on 21 December 2006

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response

scientific article

Chilling findings: the need for winter vigilance in heart failure.

scientific article published in March 2006

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

scientific article published on 30 November 2016

Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial

scholarly article by Pedro G.M. de Barros e Silva et al published October 2014 in International Journal of Cardiology

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

scientific article published on 27 January 2009

Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial

scientific article published on 01 August 2018

Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

scientific article

Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention

scientific article published on 23 May 2011

Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist

scientific article published on 01 March 2018

Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial

scientific article published on 11 June 2015

Clinical Trials Report: Cardiovascular & Renal: Ongoing and planned clinical trials in chronic heart failure and left ventricular dysfunction

Clinical Trials Series

Clinical Trials Update AHA Congress 2010.

scientific article published in February 2011

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ej

scientific article published on 04 January 2017

Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study

scientific article

Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial

scientific article published on 20 June 2015

Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme

article by Athar A. Badar et al published February 2015 in European Journal of Heart Failure

Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).

scientific article published on 10 July 2013

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program

scientific article published on 13 February 2006

Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase

scientific article published on 28 December 2010

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

scientific article published in February 2005

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

scientific article published on 19 June 2013

Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).

scientific article

Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.

scientific article published on 15 May 2016

Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program

scientific article

Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial

scientific article published on 01 April 2015

Clinical practice. Systolic heart failure.

scientific article

Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry

scientific article published on 25 August 2020

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

scientific article published on March 2010

Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.

scientific article published in December 2007

Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

scientific article published on October 2010

Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis.

scientific article

Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care ⬇️

scientific article published on August 22, 1998

Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure.

scientific article

Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.

scientific article published on 30 June 2016

Comorbidities and differential diagnosis in heart failure with preserved ejection fraction

scientific article published on July 2014

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

scientific article published on 26 July 2012

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial

scientific article published on 11 November 2014

Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.

scientific article published on November 2015

Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction

scientific article published on 17 February 2020

Comparison of Time-to-First Event and Recurrent Event Methods in Randomized Clinical Trials

scientific article published on 27 March 2018

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

scientific article published in August 2002

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

scientific article

Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus

scientific article

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

scientific article published on 04 June 2020

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

scientific article published in November 2017

Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure

scientific article published on 30 November 2017

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

scientific article published on 23 April 2016

Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry

scientific article published on 25 May 2018

Corrigendum to ‘Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved’ [Eur J Heart Fail2014;16:33-40]

scholarly article published in European Journal of Heart Failure

Corrigendum to ‘Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial’ [Eur J Heart Fail2009;11:795-801]

scholarly article published in European Journal of Heart Failure

Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388-2442 and Eur J Heart Fail 2008;10:933-989]

scholarly article published in European Journal of Heart Failure

Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388-2442 and Eur J Heart Fail 2008;10:933-989]

scholarly article published in European Journal of Heart Failure

Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’[Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989]

scholarly article published in European Heart Journal

Corrigendum to “Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker” [European Journal of Heart Failure 9/4 (2007) 429-434]

scholarly article published in European Journal of Heart Failure

Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for?

scientific article published in January 2002

Cost effectiveness of lowering cholesterol. Study greatly underestimates the cost effectiveness of statin treatment.

scientific article published on November 1996

Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure

scientific article published on 11 July 2017

Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction

scientific article

Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF

scientific article published on 04 August 2020

Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction ⬇️

scientific article published on September 1, 1997

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

scientific article

Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.

scientific article published on 21 December 2017

Covariate adjusted reanalysis of the I-Preserve trial

scientific article published on 25 March 2020

Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data

scientific article

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

scientific article published on August 2010

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

scientific article published on 06 March 2020

Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF

scientific article published on 16 July 2020

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

scientific article published on 18 December 2020

Dapagliflozin in Patients with Chronic Kidney Disease

scientific article published on 24 September 2020

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

scientific article published on 19 September 2019

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply

scientific article published on 01 March 2020

Darbepoetin Alfa in Systolic Heart Failure

scientific article published on 01 August 2013

Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial

scientific article

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns

scientific article published on 01 July 2018

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

scientific article published on 07 October 2011

Declining Risk of Sudden Death in Heart Failure

scientific article

Declining Risk of Sudden Death in Heart Failure

scientific article published on 01 November 2017

Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction

scientific article

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

scientific article published in August 2009

Determining the most appropriate components for a composite clinical trial outcome

scientific article

Developing therapies for heart failure with preserved ejection fraction: current state and future directions

scientific article

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

scientific article published on 15 March 2012

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

scientific article published on 18 April 2008

Diabetic cardiomyopathy

scientific article published on 18 October 2018

Diagnosing heart failure with preserved ejection fraction - what's the score?

scientific article published on 22 February 2020

Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients.

scientific article

Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial

scientific article published on 4 March 2016

Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function

article

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

scientific article published on 01 January 2019

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure

scientific article published on 12 March 2013

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

article

Discharge rates for suspected acute coronary syndromes: Authors' reply.

scientific article published in July 2004

Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland

scientific article published on 01 November 2008

Disease Management Programs in Cardiology

Do We Need Clinical Events Committees to Adjudicate End Points?

scientific article published on 25 June 2020

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.

scientific article published on 14 June 2013

Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.

scientific article published on 14 February 2015

Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos

scientific article published on 01 January 2005

Documento de Consenso de Expertos sobre el uso de inhibidores de la enzima de conversión de la angiotensina en la enfermedad cardiovascular

Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis

scientific article (publication date: 6 June 2006)

Does luminol chemiluminescence detect free radical scavengers? ⬇️

scientific article published on June 1, 1995

Dual Renin-Angiotensin System Blockade in Heart Failure

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine I

article

Dual renin-angiotensin system blockade and kidney disease.

scientific article published in July 2009

Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review

scientific article

Dysglycemia and Heart Failure Hospitalization

EARTH: Endothelin A Receptor Antagonist Trial in Heart Failure

ECG--still the best for selecting patients for CRT.

scientific article published on 2 September 2013

EFFECT OF DIARRHOEA ON A PATIENT TAKING CAPTOPRIL

scientific article published in The Lancet

EMPA-REG – the “diuretic hypothesis”

article

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

scientific article

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

scientific article

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

scientific article

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

scientific article published on 7 June 2017

EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.

scientific article published on 3 March 2014

Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

scientific article published on 01 December 2019

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial

scientific article published on 29 March 2017

Economic evaluation of the impact of nicorandil in angina (IONA) trial.

scientific article published on May 2006

Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation

Economics of chronic heart failure.

scientific article published in June 2001

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

scientific article published on 18 May 2017

Effect of Autophosphorylation on the Catalytic and Regulatory Properties of Protein Tyrosine Kinase Src ⬇️

scientific article published on January 1, 2002

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy ⬇️

scientific article published on 02 September 2020

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial

scientific article published on 05 July 2020

Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF

scientific article published on 04 September 2020

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

scientific article published on 27 March 2020

Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial

scientific article published on 01 June 2019

Effect of Rosuvastatin on Fatigue in Patients With Heart Failure

article

Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF

scientific article published on 01 August 2020

Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure

scientific article published on 12 April 2017

Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure

scientific article published in July 2001

Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure

article

Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trial

scientific article published in August 2011

Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction

scientific article published on 19 November 2007

Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor

scientific article (publication date: 2002)

Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

scientific article published in November 2004

Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

scientific article published on 4 October 2004

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

scientific article

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

scientific article published on 21 August 2020

Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction

scientific article published on 01 March 2018

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial

scientific article

Effect of nateglinide on the incidence of diabetes and cardiovascular events

scientific article published on 14 March 2010

Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial

scientific article published on 13 April 2018

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

scientific article

Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).

scientific article published on 30 April 2014

Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

scientific article published on 12 February 2018

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.

scientific article

Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT

scientific article published on 09 May 2016

Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study

article

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials

scientific article

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

scientific article published on 28 May 2015

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

article

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

scientific article published on 17 January 2017

Effect of valsartan on the incidence of diabetes and cardiovascular events

scientific article

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial

scientific article published on 17 November 2019

Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat

article

Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF

scientific article published on 17 November 2019

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease

scientific article published on 01 October 2018

Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy

scientific article published on September 2016

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

scientific article published on 01 February 2019

Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction

scientific article published on 26 March 2020

Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial

scientific article published on 01 June 2018

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial

scientific article published on 11 October 2017

Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study

scientific article published on 24 November 2020

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

scientific article published on 12 September 2017

Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker

scientific article published on 27 November 2006

Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial

scientific article published on 07 November 2019

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

scientific article published in September 2003

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

scientific article

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

scientific article

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

scientific article

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

scientific article published on 27 June 2005

Effects of dalcetrapib in patients with a recent acute coronary syndrome

scientific article

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

scientific article published on 28 March 2020

Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials

scientific article published in 2023

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

scientific article

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

scientific article published in May 2008

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

scientific article

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

scientific article published in May 2008

Effects of the xanthine oxidase system on cardiac function in anaesthetised rats

scientific article published on 01 September 1993

Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course

scientific article published on 01 June 1991

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF

scientific article published on 17 November 2019

Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis

scientific article published on 28 August 2016

Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.

scientific article

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme

scientific article published on 23 April 2010

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

scientific article

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

scientific article published on 2 May 2013

Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.

scientific article

Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF

scientific article published on 15 June 2020

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in He

scientific article

Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial

scientific article published on 25 June 2016

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction

scientific article published on 28 January 2019

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

scientific article published on 10 June 2016

Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice.

scientific article

Elevated serum and monocyte tumour necrosis factor alpha in patients with congestive heart failure

scientific article published on 01 December 1999

Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.

scientific article published on 02 October 2014

Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.

scientific article published on 16 November 2017

End of the Road for Vagus Nerve Stimulation? ∗

Endothelin receptor antagonism in patients with chronic heart failure

scientific article published on 01 July 2000

Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.

scientific article

Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance

scientific article

Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction.

scientific article published on December 2006

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study

scientific article published in May 2012

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

scientific article published on 19 May 2012

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms ⬇️

scientific article published on November 14, 2010

Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations

scientific article published on 05 October 2012

Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].

scientific article published in June 2016

Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

scientific article published on 12 May 2016

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

article

Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis

scientific article published on 01 December 2018

Estimated Long-Term Survival With Eplerenone

scientific article published on 01 May 2019

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

scientific article published on 21 May 2020

Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan

article

Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data

scientific article

European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department

scientific article

European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care

scientific article published on 29 June 2015

Evaluating dyspnoea in acute heart failure: progress at last!

scientific article published on 18 February 2010

Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study

scientific article published on 22 March 2010

Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications

scientific article published on 01 February 2014

Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).

scientific article published in February 2011

Event Rates in Trials of Patients With Type 2 Diabetes

scientific article published in The Journal of the American Medical Association

Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease

article

Evidence for oxidative stress in unstable angina ⬇️

scientific article published on November 1, 1992

Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure

scientific article published on 27 November 2017

Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation

scientific article published on April 2011

Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure

scientific article (publication date: 27 April 2017)

Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure

scientific article published on 19 June 2019

Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

article published in 2006

Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure

article

Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial

scientific article published on June 2016

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

article

Failing ageing hearts

scientific article published on 01 November 2001

Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials.

scientific article published on August 2015

Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).

scientific article published on July 2010

Fatigue as a Predictor of Outcome in Patients With Heart Failure

article

Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply

From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)

scientific article published on 01 August 2019

Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man

scientific article published on 01 January 1988

Galectin-3 and cardiac function in survivors of acute myocardial infarction.

scientific article published on 15 March 2013

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) ⬇️

scientific article published on April 17, 2012

Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.

scientific article published on 25 June 2009

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis

scientific article published on 8 March 2012

Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction

article

Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

scientific article published on 09 January 2020

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).

scientific article

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

scientific article (publication date: September 2006)

Geographic variations in the PARADIGM-HF heart failure trial.

scientific article published on 28 June 2016

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization

scientific article published on 21 September 2020

Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial

scientific article published on 11 September 2018

Gut feelings about heart failure.

scientific article

Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012

HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure--lessons learnt from a decade of trials

scientific article published in February 2010

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

scientific article published on 24 September 2014

Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics

scientific article published on 12 June 2018

Health-Related Quality of Life Outcomes in PARADIGM-HF.

scientific article

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

scientific article published on 10 July 2019

Heart Failure

Heart Failure

Heart Failure After Acute Myocardial Infarction

article

Heart Failure With Preserved Ejection Fraction in the Young

scientific article published on 01 December 2018

Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis.

scientific article published on 19 June 2017

Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus

scientific article

Heart failure

scientific article published in The Lancet

Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists

scientific article published on May 2011

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

scientific article

Heart failure and chronic obstructive pulmonary disease: lung function test interpretation: reply

scholarly article by Nathaniel M. Hawkins et al published 25 May 2009 in European Journal of Heart Failure

Heart failure and socioeconomic status: accumulating evidence of inequality

scientific article

Heart failure care in low- and middle-income countries: a systematic review and meta-analysis

scientific article

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

scientific article

Heart failure in 2011: Heart failure therapy--technology to the fore.

scientific article published on 25 January 2012

Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality.

scientific article published in March 2002

Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)

scientific article

Heart failure management programs reduce readmissions and prolong survival

scientific article published on 01 June 2005

Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry

scientific article published on 21 June 2005

Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum

scientific article published on 12 February 2018

Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.

scientific article

Heart failure with preserved left ventricular systolic function: a hospital cohort study

scientific article published on July 2005

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

scientific article published on February 2004

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas

scientific article published on 10 December 2018

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored

scientific article published on 13 March 2014

Heart failure: are we neglecting the silent majority?

scientific article published on 25 April 2007

Heart failure: we need more trials in typical patients

scientific article published on 01 May 2000

Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm

article

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial

scientific article published on 28 December 2020

High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

scientific article published on 31 January 2008

High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.

scientific article published on 12 February 2014

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

scientific article published on 19 September 2013

History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction

scientific article published on 15 September 2014

Hospital-at-home care for CHF—verdict, 'not proven'

scientific article published on 01 February 2010

How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials

scientific article published on 30 January 2020

How robust are clinical trials in heart failure?

scientific article published on 14 October 2016

How should we optimize cardiac resynchronization therapy?

scientific article published on 28 August 2008

How small is too small? A systematic review of center volume and outcome after cardiac transplantation

scientific article

Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome

scientific article published on 25 March 2020

Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations

scientific article published in February 2018

Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF

scientific article published on 3 October 2014

IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure

scientific article published on 01 October 2018

Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pr

scientific article published in November 2016

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

scientific article published on 01 December 2019

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR.

scientific article

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

scientific article (publication date: 12 October 2005)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

scientific article published on 14 April 2008

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate

scientific article published on 02 January 2019

Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis.

scientific article published on 05 June 2010

Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure

scientific article published on 11 November 2008

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials

scientific article published on 27 September 2018

Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study.

scientific article published on 22 November 2017

Impaired left atrial function in heart failure with preserved ejection fraction.

scientific article published on 19 August 2014

Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.

scientific article published on 30 October 2013

Impaired vascular responsiveness to nitric oxide in renal transplant recipients

scientific article published on 01 February 1999

Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).

scientific article published on 20 April 2016

Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.

scientific article published on 2 December 2016

Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992.

scientific article published in December 1998

Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial

scientific article

Improving outcomes in heart failure: a personal perspective

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program

scientific article published on 29 October 2007

Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study

scientific article

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research tri

scientific article published on 7 October 2013

Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiot

scientific article

Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result

scientific article published on 02 December 2013

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis

scientific article published on 06 February 2019

Income level and inequality as complement to geographical differences in cardiovascular trials

scientific article published on 01 September 2019

Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993 ⬇️

scientific article published on October 1, 1997

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide

scientific article published on 2 April 2007

Increased mortality after dronedarone therapy for severe heart failure

scientific article

Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy

scientific article

Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease

scientific article

Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

scientific article published in October 2017

Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study

scientific article published on March 2004

Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction

article

Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial

article

Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in

scientific article

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

scientific article published on February 2009

Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.

scientific article published on 3 December 2013

Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Fai

scientific article published on March 2016

Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

article

Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization

scientific article published in July 2016

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

scientific article

Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction

scientific article published on 17 October 2014

Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction

scientific article

Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial

scientific article published on 21 December 2015

Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.

scientific article published on 12 May 2016

Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial

scientific article published on 16 September 2016

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction

scientific article published on 04 July 2019

Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.

scientific article published on 7 October 2011

Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: a post-hoc analysis of the SONAR trial

scientific article published on 12 November 2020

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure

scientific article published on 02 March 2020

Interleukin-21 – A biomarker of importance in predicting myocardial function following acute infarction?

scientific article published on 27 June 2012

Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).

scientific article published on 25 May 2010

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial.

scientific article published on 13 January 2017

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction

scientific article published on 18 November 2014

Interventions to prevent readmission for congestive heart failure

scientific article published on 01 June 2004

Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial

scientific article published on 06 April 2020

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis

article published in 2018

Irbesartan in patients with heart failure and preserved ejection fraction

scientific article

Iron deficiency: an ominous sign in patients with systolic chronic heart failure

scientific article

Iron status in patients with chronic heart failure

scientific article published on 23 November 2012

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.

scientific article published on 29 October 2015

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis

scientific article published on 11 September 2015

Is microvolt T-wave alternans the answer to risk stratification in heart failure?

scientific article published on December 2007

Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?

scientific article

It is BEAUTIFUL we should be concerned about, not SIGNIFY: is ivabradine less effective in ischaemic compared with non-ischaemic LVSD?

scientific article published on 20 May 2015

Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report

article

Large streamlined trials in cardiovascular disease

scientific article published on 2 January 2014

Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study

scientific article published on 11 November 2008

Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.

scientific article

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 10 April 2013

Lessons from the TOPCAT Trial

article

Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.

scientific article

Letter by MacDonald et al Regarding Article, "Catheter Ablation of Atrial Fibrillation"

Letters to the Editor

scientific article published on 01 March 1999

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone ⬇️

scientific article published on November 1, 2001

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

scientific article published on April 2017

Lipid-modifying therapies and risk of pancreatitis: a meta-analysis

scientific article published in August 2012

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

scientific article

Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.

scientific article published on 28 December 2015

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

scientific article

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

scientific article published in May 2017

Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study)

scientific article published on 23 September 2005

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

scientific article

Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience

Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.

scientific article published on 19 January 2009

Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction

scientific article published on November 2010

Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.

scientific article published on 23 January 2015

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction

scientific article published on 23 December 2015

Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE.

scientific article published on 29 August 2013

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).

scientific article published on 21 June 2016

Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure

scientific article published on 15 April 2005

Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes

scientific article published on 01 October 2019

Lung ultrasound: monitoring congestion in patients with heart failure

scientific article published on 08 November 2019

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT

scientific article published on 01 December 2019

Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials

scientific article

Making sense of SENIORS.

scientific article published on 11 January 2005

Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study.

scientific article

Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative

scientific article published on 05 April 2019

Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Stud

scientific article

Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction

scientific article

Medical management of advanced heart failure

Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure

scientific article published on 9 April 2015

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.

scientific article published on 7 November 2013

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

scientific article published on 04 March 2019

Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct

scientific article

Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction

scientific article published on 10 July 2019

Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial

scientific article published on 04 May 2018

Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction.

scientific article published on 26 March 2010

Microvolt T-Wave Alternans Testing Has No Role at Present in Guiding Therapy for Patients at High Risk of Ventricular Arrhythmias

scientific article published on 01 February 2012

Microvolt T-wave alternans testing in patients recently hospitalized with decompensated heart failure

scientific article published on 14 December 2013

Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply

Mind the Gap: Current Challenges and Future State of Heart Failure Care

scientific article published on 5 September 2017

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

scientific article published on 08 January 2020

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice

scientific article published on 31 August 2012

Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function

scientific article published on 24 January 2007

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

scientific article

Monocyte chemoattractant protein-1: a dichotomous role in cardiac remodeling following acute myocardial infarction in man?

scientific article published on 17 March 2010

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

article

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

scientific article published on 18 October 2004

Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial.

scientific article published on 18 July 2015

Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.

scientific article published in August 2004

Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry

scientific article published on 27 March 2018

Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials

scientific article published on 06 May 2020

Myocardial infarct: no one size fits all.

scientific article published in June 2002

Myocardial metabolic manipulation: a new therapeutic approach in heart failure?

scientific article published in February 2005

N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status

scientific article published on 01 March 2019

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

scientific article published on 3 April 2013

N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

scientific article published on 5 August 2018

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

scientific article published on 23 September 2020

Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure

scientific article published on 4 March 2018

Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure.

scientific article

Neprilysin Inhibition for Heart Failure

scientific article published on 01 December 2014

Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances

scientific article

Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).

scientific article published on 29 July 2014

Neuroendocrine changes post myocardial infarction: Effects of xamoterol

scientific article published on 01 July 1990

Neurohormonal activation in acute heart failure: results from VERITAS.

scientific article published on 8 September 2011

Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study

scientific article published on 4 April 2011

Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure

scientific article published on 18 October 2007

Neurohumoral pathways in heart failure with preserved systolic function

scientific article

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment

scientific article published on 27 March 2017

New therapeutic options in congestive heart failure: Part I.

scientific article

New therapeutic options in congestive heart failure: Part II.

scientific article

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

scientific article published on 13 September 2004

Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.

scientific article

Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer

scientific article published on 01 November 1990

Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial

scientific article published on 7 November 2014

Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1

scientific article published on 01 March 1999

Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms

scientific article published on 22 April 2020

Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction, GALACTIC-HF: Baseline Characteristics and Comparison with Contemporary Clinical Trials

scientific article published on 27 September 2020

Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF

scientific article published on 06 February 2020

Optimizing heart failure treatment following cardiac resynchronization therapy

scientific article published on 26 September 2019

Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups

scientific article published on 19 June 2013

Outcome from a rapid-assessment chest pain clinic ⬇️

scientific article published on 01 May 1998

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF

scientific article published on 08 May 2019

Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.

scientific article published on April 2006

PARADIGM-HF — The Experts' Discussion

article

PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction

scientific article published on 01 November 2019

Palliative care for heart failure

scientific article published on October 2002

Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology

scientific article published on May 2009

Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design

scientific article published on 19 March 2015

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both

scientific article published on 26 July 2010

Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

scientific article published in June 2005

Patients strategies for managing medication for chronic heart failure

scientific article published on 01 July 2005

Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.

scientific article published on 26 November 2012

Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it

scientific article published on 11 April 2019

Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction

scientific article

Pharmacologic management of patients with both heart failure and diabetes

scientific article published on June 2009

Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?

scientific article published on 28 November 2012

Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

article

Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?

scientific article published on 01 August 2019

Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

scientific article published on 12 April 2015

Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

scientific article published on 01 March 1999

Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study

scientific article

Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in

scientific article

Pneumonia

scientific article published on 01 September 1986

Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocc

article

Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction

scientific article published on 01 April 2010

Practical approach on frail older patients attended for acute heart failure

scientific article

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.

scientific article published in August 2001

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice

scientific article published in August 2005

Prediabetes and the risk of diabetes

scientific article published on 01 October 2012

Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction

scientific article published on 27 June 2016

Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges.

scientific article published on 14 December 2015

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

scientific article

Predictive value of endostatin in chronic heart failure patients with poor kidney function

scientific article published on 22 November 2014

Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS.

scientific article published on 22 December 2015

Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction

article

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial

scientific article

Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models

scientific article published on 11 April 2015

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program

scientific article published on 05 February 2009

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

scientific article published on 24 January 2009

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

article

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study

scientific article

Predictors of mortality and morbidity in patients with chronic heart failure

scientific article

Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.

scientific article published on 19 September 2006

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

scientific article published on 30 July 2013

Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial

scientific article published on 23 October 2009

Predictors of sudden cardiac death in high-risk patients following a myocardial infarction

scientific article published on 16 January 2020

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

scientific article published on 28 February 2008

Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities

scientific article published on 24 November 2008

Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: Analysis of 1598 patients and 4588 patient-years follow-up

scientific article published on 02 January 2019

Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme

scientific article published on 20 February 2007

Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality

scientific article

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

scientific article published on 25 September 2017

Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study

scientific article (publication date: August 2006)

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

scientific article published on 01 July 2006

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

scientific article

Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction

scientific article published on 28 February 2006

Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland

scientific article published on 30 November 2009

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF

scientific article published on 11 November 2019

Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

scientific article published on 10 April 2019

Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study

scientific article published on 25 August 2018

Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure

article

Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF

scientific article published on 4 April 2019

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

scientific article published in December 2016

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF

scientific article published on 12 September 2019

Prognostic Modeling in Heart Failure: Time for a Reboot

scientific article published on 01 June 2018

Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure

scientific article published on 29 January 2020

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure

scientific article

Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction

scientific article published on 15 June 2016

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation

scientific article

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial

scientific article

Prognostic impact of pulmonary arterial hypertension: A population-based analysis

article

Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study

scientific article

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.

scientific article published on 27 September 2017

Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program

scientific article published on 2 November 2014

Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

scientific article published on 26 May 2013

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial

scientific article published on 29 June 2011

Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study

scientific article

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

scientific article

Public awareness of heart failure in Europe: first results from SHAPE

article

Pulmonary and Systemic Responses to Exogenous Endothelin-1 in Patients with Left Ventricular Dysfunction ⬇️

scientific article published on January 1, 1998

Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)

scientific article published on 26 March 2015

QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?

article

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

scientific article published on 22 May 2015

Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both

scientific article published in May 2008

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

scientific article published on 4 November 2010

Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data

scientific article published on 10 October 2018

Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week

scientific article published on 01 August 2020

Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).

scientific article published on 4 October 2016

Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure

scientific article published on 06 June 2019

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

scientific article

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

scientific article published on 13 April 2010

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

scientific article published in December 2009

Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction

scientific article published on 17 September 2018

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

scientific article published on 28 February 2013

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

scientific article published on 5 April 2014

Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure

scientific article published on 13 November 2016

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

scientific article published on 12 February 2015

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

article

Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits

article by Li Shen et al published August 2017 in JACC: Heart Failure

Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort

scientific article published on 30 March 2020

Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Em

scientific article published on 21 May 2015

Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank

scientific article

Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure.

scientific article published in December 2009

Redefining heart failure phenotypes based on ejection fraction

scientific article published on 17 October 2018

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial

scientific article

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial

scientific article published on 11 February 2019

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales).

scientific article

Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction.

scientific article published on 3 November 2015

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

scientific article (publication date: 23 September 2004)

Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative).

scientific article published on 5 February 2018

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)

scientific article published on 03 August 2018

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

scientific article published on 12 July 2011

Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

scientific article published on 28 September 2014

Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.

scientific article published on 19 July 2018

Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).

scientific article published on 23 May 2014

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction

scientific article published on 17 December 2019

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

article by John McMurray et al published May 2006 in American Heart Journal

Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.

scientific article published on June 2015

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

scientific article published on 5 April 2018

Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.

scientific article published on 6 February 2015

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

scientific article published in February 2006

Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myoc

scientific article

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial

scientific article published on 15 February 2019

Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.

scientific article published on 13 January 2016

Renin angiotensin blockade in heart failure with preserved ejection fraction: the signal gets stronger

scientific article published on 08 September 2006

Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data

scientific article

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19

scientific article published on 30 March 2020

Reply

Reply

Reply

Reply

Reply to the letter by Dr Erqou regarding “Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients”

Reply: An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition

scientific article published on 01 November 2017

Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF

scientific article published on 01 March 2020

Reply: Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction

scientific article published on 01 March 2020

Reply: Mineralocorticoid Receptor Antagonists, Blood Pressure, and Drug Discontinuation

scientific article published on 01 July 2020

Reply: NT-proBNP in Heart Failure With Preserved Ejection Fraction: Quest for a Marker Reflecting the Truth

scientific article published on 01 July 2020

Reply: The PARAGON-HF Trial: Toward Extension to Patients With HF Middle Range Ejection Fraction

scientific article published on 01 August 2020

Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device

scientific article published on 01 March 2018

Reply: To PMID 23141494.

scientific article

Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF?

scientific article published in October 2014

Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review.

scientific article published on May 2016

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).

scientific article published in August 2005

Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

scientific article published in June 2006

Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials"

scientific article published on 01 January 2019

Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"

scientific article published on 06 July 2020

Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della So

scientific article published in December 2015

Response to Letter Regarding Article, “Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas”

Response to Letter Regarding Article, “Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction”.

scientific article published in July 2013

Response to Letter Regarding Article, “Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure”

Response to Letter Regarding Article, “Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both”

Response to The J-Point Revisited

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

scientific article

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

scientific article

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia.

scientific article

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration

scientific article published on 16 December 2018

Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study

scientific article published on 9 August 2016

Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial

scientific article

Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl

scientific article published on 13 October 2014

Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction

scientific article published on 06 April 2018

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

scientific article published on 25 March 2015

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials

scientific article

Risk prediction in patients with heart failure: a systematic review and analysis

scientific article published on 03 September 2014

Risk stratification according to insulin type: reply.

scientific article

Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

scientific article published on 29 May 2017

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

scientific article

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

scientific article

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

scientific article

Rosuvastatin in older patients with systolic heart failure

scientific article

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

scientific article

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review

scientific article published on 22 August 2018

Sacubitril/Valsartan (LCZ696) in Heart Failure

scientific article published on 01 January 2017

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

scientific article published on 17 November 2019

Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis

scientific article published on 04 September 2020

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction.

scientific article published in June 2019

Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF

scientific article published on 01 October 2020

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.

scientific article published on 30 November 2017

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

article

Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides ⬇️

scientific article published on November 1, 2003

Seasonal variation in morbidity and mortality related to atrial fibrillation.

scientific article

Seasonal variations in cardiovascular disease

scientific article

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

scientific article published on 19 August 2015

Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?

scientific article

Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony.

scientific article published on May 2009

Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology

scientific article published on 10 December 2010

Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative

scientific article

Serum Uric Acid, Influence of Sacubitril/Valsartan, and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: PARAGON-HF

scientific article published on 25 August 2020

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

scientific article

Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment

scientific article published on September 2016

Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure

article

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

scientific article published on 10 August 2012

Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005.

scientific article

Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials

scientific article published on 19 February 2020

Sex-Related Differences in Heart Failure With Preserved Ejection Fraction

scientific article published on 09 December 2019

Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry

article

Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction

scientific article published on 23 February 2014

Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study.

scientific article published on 14 June 2006

Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure

scientific article published on 08 March 2012

Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? ⬇️

scientific article published on 01 June 1998

Site Selection and Performance in Clinical Trials

Site selection for heart failure clinical trials in the USA.

scientific article published in July 2015

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

scientific article published on 2 February 2012

Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

scientific article published on 10 December 2012

Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure

article

Statins and chronic heart failure: do we need a large-scale outcome trial?

scientific article

Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence

scientific article published on 27 July 2019

Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials.

scientific article published on December 2015

Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation

scientific article published in February 2018

Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.

scientific article

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

scientific article published on 17 January 2020

Substantial between-hospital variation in outcome following first emergency admission for heart failure.

scientific article published in April 2002

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

article

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population ⬇️

scientific article published on September 20, 1997

Synergism of histidyl dipeptides as antioxidants

article

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan

scientific article published on 16 March 2020

Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?

scientific article published on 4 September 2017

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.

scientific article published in February 2017

Talking to patients with heart failure about end of life

scientific article published on 08 October 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

scientific article published on 15 March 2004

Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).

scientific article

Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals

scientific article published on 03 September 2019

Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals

scientific article published on 21 November 2017

Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005.

scientific article

Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland

scientific article

Terminology and definition of changes renal function in heart failure.

scientific article published on 24 August 2014

Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).

scientific article published in July 2005

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.

scientific article published in October 2015

The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context

scientific article published on 03 January 2020

The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics

scientific article published on 15 July 2019

The Emerging Potential of the Apelin-APJ System in Heart Failure.

scientific article published on 18 March 2015

The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics

scientific article published in August 2011

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

scientific article published on 14 May 2015

The ICD in Heart Failure - Time for a Rethink?

scientific article

The J-curve hypothesis

scientific article published in The Lancet

The Metabolodiuretic Promise of Sodium-Dependent Glucose Cotransporter 2 Inhibition: The Search for the Sweet Spot in Heart Failure

scientific article published on 01 September 2017

The Serendipitous Story of SGLT2 Inhibitors in Heart Failure

scientific article published on 18 March 2019

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

scientific article published on 26 August 2012

The assessment of the HO· scavenging action of therapeutic agents

scientific article published on 01 July 1994

The association between meteorological events and acute heart failure: new insights from ASCEND-HF.

scientific article published on 6 November 2014

The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA* ⬇️

scientific article published on January 16, 2012

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

scientific article published on 14 October 2015

The clinical relevance of adrenomedullin: a promising profile?

scientific article published in September 2004

The complex nature of informal care in home-based heart failure management

scientific article published on February 2008

The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry

scientific article published in January 2006

The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting

scientific article

The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans

scientific article published on 28 March 2012

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

scientific article

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

scientific article published on 26 January 2006

The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.

scientific article published on 14 March 2017

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

scientific article

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality

scientific article published in August 2008

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

scientific article published on 17 July 2013

The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients

scientific article published on 6 December 2013

The incremental prognostic and clinical value of multiple novel biomarkers in heart failure

scientific article published on 25 April 2016

The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction

scientific article published on November 2010

The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design

scientific article

The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.

scientific article published on 24 October 2013

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan

scientific article

The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure

scientific article published on 08 May 2020

The past, present and future of renin-angiotensin aldosterone system inhibition

scientific article

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

scientific article published on 29 October 2012

The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE

scientific article published on 30 April 2020

The prevalence, nature, and importance of hematologic abnormalities in heart failure

scientific article

The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis

scientific article published on 4 August 2009

The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes

scientific article published on 10 December 2018

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

scientific article published on 10 September 2007

The reproducibility of symptoms during a submaximal exercise test in chronic heart failure.

scientific article published on March 1998

The rise and fall of myotrophin in heart failure**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology

scientific article published on 01 August 2003

The role of angiotensin II receptor blockers in the management of heart failure

The statin wars

scientific article

The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

scientific article published on June 2006

The year in cardiology: heart failure

scientific article published on 01 March 2020

The year in heart failure

scientific article

Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis

scientific article

Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial

scientific article

Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).

scientific article published on 25 January 2014

Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials? ⬇️

scientific article published on August 27, 2012

Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction

scientific article published on 30 March 2020

Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency

scientific article published on 12 April 2016

Transthoracic echocardiography: a survey of current practice in the UK

scientific article published on 15 February 2008

Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.

scientific article published in December 2016

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

scientific article published on 19 December 2018

Treatment of anemia with darbepoetin alfa in systolic heart failure

scientific article published on 10 March 2013

Treatment of chronic heart failure: a comparison between the major guidelines

scientific article published on 4 July 2006

Treatment of heart failure with spironolactone--trial and tribulations

scientific article

Treatment of severe hypertriglyceridaemia

scientific article published on 20 March 2014

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database ⬇️

scientific article

Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995.

scientific article published on March 2002

Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996

article

Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?

article

Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986-2005: a retrospective cohort study

scientific article

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

scientific article published on 4 July 2012

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

scientific article published on 8 March 2018

Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction

scientific article published in November 2017

Uncertainty in the treatment of anemia in chronic kidney disease.

scientific article

Updated risk factors should be used to predict development of diabetes.

scientific article

Use of the Win Ratio in Cardiovascular Trials

scientific article published on 01 June 2020

Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)

article

Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).

scientific article

Using measures of disease progression to determine therapeutic effect: a sirens' song

scientific article published on 12 July 2006

VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context

scientific article published in August 2003

VICTORIA in context

scientific article published on 03 May 2020

Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?

scientific article published in March 2005

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

scientific article published in November 2000

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

scientific article published on 10 November 2003

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales.

scientific article published on 16 August 2016

Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial

scientific article published on 20 November 2014

Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial

scientific article published on 01 March 2020

Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials

scientific article published on 01 August 2018

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

scientific article

What are the clinical consequences of anemia in patients with chronic heart failure?

scientific article published on February 2004

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?

scientific article

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

scientific article

What works in chronic care management: the case of heart failure.

scientific article published in January 2009

When to stop a clinical trial early for benefit: lessons learned and future approaches

scientific article published on March 2012

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

scientific article

Which patients with heart failure should receive specialist palliative care?

scientific article published on 28 June 2018

Who Benefits From a Defibrillator-Balancing the Risk of Sudden Versus Non-sudden Death

Why and when should we worry about worsening renal function?

scientific article published on 4 December 2013

Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis

scientific article published on 12 October 2017

World Heart Federation Roadmap for Heart Failure

scientific article published on 01 September 2019

Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study

article

Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.

scientific article

Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme

scientific article

Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.

scientific article published in March 2005

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

scientific article published on 01 December 2004

β blockers, atrial fibrillation, and heart failure

scientific article published in The Lancet

β1-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications

scientific article published on 20 January 2020

Paulina is supported by:

About Paulina

Help